A group of Democratic senators are calling on Health and Human Services Secretary Robert F. Kennedy Jr. to keep a proposed ...

A U.S. senator said a GLP-1 drug changed his life — and now he’s calling for widespread access to anti ... Medicare covers ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

As discussions unfold, Kennedy seeks to balance drug accessibility with concerns about the long-term costs of providing GLP-1 ...

As President Trump wages war on wasteful spending and DEI, a $16 billion-a-year health equity program is flying under the ...

A decision by CMS to not move forward with a proposed rule allowing obesity medications to be covered under Medicare Part D ...

A novel drug that produces a temporary coating in the small intestine could be a new strategy for weight loss—and an alternative to surgeries and GLP-1 drugs.

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

Senator John Fetterman (D-PA) revealed he’s using a weight loss drug and is now asking the Trump Administration to make it ...

Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access ...

The Trump administration is not finalizing a Biden-era provision that would expand coverage of anti-obesity drugs under ...

Medicare Advantage updates while halting proposed anti-obesity drug coverage, impacting millions of potential beneficiaries.